Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 4
2005 1
2006 1
2008 1
2009 1
2010 3
2011 1
2012 3
2013 3
2014 5
2015 11
2016 9
2017 7
2018 3
2019 2
2020 4
2021 10
2022 5
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Genomic Landscape of Circulating Tumor DNA in Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Treated With Abemaciclib: Data From the SCRUM-Japan Cancer Genome Screening Project.
Hattori M, Serelli-Lee V, Naito Y, Yamanaka T, Yasojima H, Nakamura R, Fujisawa T, Imai M, Nakamura Y, Bando H, Kawaguchi T, Yoshino T, Iwata H. Hattori M, et al. Among authors: kawaguchi t. JCO Precis Oncol. 2024 Apr;8:e2300647. doi: 10.1200/PO.23.00647. JCO Precis Oncol. 2024. PMID: 38635933
Risk factors for recurrence in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative early breast cancer in Japan: a systematic literature review and meta-analysis.
Miyazaki N, Iwasaki T, Sakai H, Watanuki R, Tanizawa Y, Cai Z, Kawaguchi T, Tsurutani J, Nagashima K. Miyazaki N, et al. Among authors: kawaguchi t. Curr Med Res Opin. 2024 Apr 10:1-11. doi: 10.1080/03007995.2024.2332436. Online ahead of print. Curr Med Res Opin. 2024. PMID: 38597173 Review.
Patient characteristics, treatment patterns, and outcomes of hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer patients prescribed cyclin-dependent kinase 4 and 6 inhibitors: large-scale data analysis using a Japanese claims database.
Kawai M, Takada M, Nakayama T, Masuda N, Shiheido H, Cai Z, Huang YJ, Kawaguchi T, Tanizawa Y. Kawai M, et al. Among authors: kawaguchi t. Breast Cancer Res Treat. 2023 Jan;197(2):435-447. doi: 10.1007/s10549-022-06816-9. Epub 2022 Nov 21. Breast Cancer Res Treat. 2023. PMID: 36414795 Free PMC article.
Safety in Japanese Advanced Breast Cancer Patients Who Received Abemaciclib in MONARCH 2 and MONARCH 3: Assessment of Treatment-Emergent Neutropenia, Diarrhea, and Increased Alanine Aminotransferase and Aspartate Aminotransferase Levels.
Masuda N, Chen Y, Kawaguchi T, Dozono K, Toi M. Masuda N, et al. Among authors: kawaguchi t. Cancer Manag Res. 2022 Mar 19;14:1179-1194. doi: 10.2147/CMAR.S348591. eCollection 2022. Cancer Manag Res. 2022. PMID: 35342308 Free PMC article.
Validation of a claims-based algorithm to identify cases of ulcerative colitis in Japan.
Ogino H, Morikubo H, Fukaura K, Okui T, Gardiner S, Sugiyama N, Yoshii N, Kawaguchi T, Chen H, Nonnenmacher E, Setoguchi S, Nakashima N, Kobayashi T. Ogino H, et al. Among authors: kawaguchi t. J Gastroenterol Hepatol. 2022 Mar;37(3):499-506. doi: 10.1111/jgh.15732. Epub 2021 Nov 26. J Gastroenterol Hepatol. 2022. PMID: 34738649 Free PMC article.
74 results